EDGAR Filing Documents for 0001144204-15-042901

Form 8-K - Current report:

SEC Accession No. 0001144204-15-042901

Filing Date

2015-07-16

Accepted

2015-07-16 17:30:35

Documents

Period of Report

2015-07-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v415576_8k.htm	8-K	58297
2	EXHIBIT 2.1	v415576_ex2-1.htm	EX-2.1	426539
3	EXHIBIT 3.2	v415576_ex3-2.htm	EX-3.2	88117
4	EXHIBIT 10.1	v415576_ex10-1.htm	EX-10.1	50590
5	EXHIBIT 99.1	v415576_ex99-1.htm	EX-99.1	25782
	Complete submission text file	0001144204-15-042901.txt		650968

Mailing Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154

Business Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154 5184640279

ALBANY MOLECULAR RESEARCH INC (Filer) CIK: 0001065087 (see all company filings)